Scrip    Clinica    RAJ    Scrip Clinical Research    AnimalPharm
Email ID
Password
Forgotten your password?
Home
Therapy Sector
Generics
Business
Policy & Regulation
Research & Development
International
News
|
Comment
|
Features
|
Analysis
|
Supplements & Reports
|
People
|
Events
|
Multimedia
|
Science Abstracts
|
Pharma could hide adverse drug reaction reports under EU plans, NGOs say
08 February 2010
Eight organisations representing consumers, health insurers, healthcare professionals and NGOs are worried that the European Commission's draft legislative ...
Ex-BMS employee in US charged with trade-secret theft of SOPs
08 February 2010
US federal authorities have said that an ex-employee of Bristol-Myers Squibb in upstate New York has been arrested and charged with stealing trade secrets and ...
GSK to cut hundreds, not thousands of UK jobs
05 February 2010
GlaxoSmithKline is to expand its restructuring programme to deliver a further £500 million in pre-tax savings by 2012. The company plans to cease research into ...
US judge hears case challenging Myriad patents on BRCA cancer genes
04 February 2010
A US federal judge heard arguments on February 2nd in a lawsuit questioning the patentability of isolated human genes. However, it could be months before ...
 
AstraZeneca and CRT to develop cancer metabolism targeted therapies
08 February 2010
Cancer Research Technology (CRT) will collaborate with AstraZeneca to create a slate of new anticancer therapies over the next three years. CRT, the commercial and development arm of Cancer Research ...
Cartilage replacement company spun out from Cardiff University
08 February 2010
Fusion IP, a UK-based university technology commercialisation company, has created a new spin-out company, Progenteq, under its exclusive agreement with Cardiff University. Progenteq is at the early ...
Venus launches infused combination GI product in India
08 February 2010
Venus Remedies of India has launched on the domestic market a combination of the fluoroquinolone antibiotic ofloxacin and the nitroimidazole antiprotozoal compound ornidazole in infusion form, as ...
Interview: Rexbio sets sights on novel approach to pancreatic cancer
08 February 2010
The South Korean bioventure Rexbio is looking to develop a novel approach to the treatment and diagnosis of one of the most deadly forms of cancer by targeting a gene found to be closely linked to ...
 
Roche/Ipsen push taspoglutide filing back to 2011
08 February 2010
Roche / Ipsen have announced that they will file the GLP-1 analogue taspoglutide for type 2 diabetes in 2011, back from previous expectations that it would be filed in the fourth quarter of this ...
Takeda launches Mepact in EU for osteosarcoma
05 February 2010
Takeda Pharmaceuticals Europe has launched its anti-cancer Mepact (mifamurtide) in the EU for the treatment of adjuvant osteosarcoma (bone cancer). The drug is presently available via a paid ...
Daiichi Sankyo's edoxaban enters pivotal trial for VTE
04 February 2010
Daiichi Sankyo has begun recruiting for a key Phase III multinational clinical trial programme for its oral direct Factor Xa inhibitor, edoxaban. The pivotal HOKUSAI VTE study will compare the ...
Synosia reports early clinical data for Parkinson's candidate
04 February 2010
Synosia Therapeutics has reported some potentially positive interim results from a Phase IIa study investigating its experimental adenosine 2a (A2a) receptor antagonist SYN-115 as an adjunctive ...
 
Ranbaxy's US facility gets FDA warning letter
08 February 2010
The US FDA 's recent warning letter to Ohm Laboratories over good manufacturing practice (GMP) deviations at its plant in Gloversville, New York, includes concerns over certain postmarketing and ...
US FDA prepares for biosimilars in 2011 budget plan, despite stalled reform bill
08 February 2010
As part of the unveiling of the Obama administration's fiscal year 2011 budget, FDA officials outlined how the agency plans to prepare for an approval pathway for follow-on biologics (or ...
Novartis defends South Korean pricing of Glivec
05 February 2010
Novartis has rebutted suggestions that it has resisted attempts to reduce the cost of its leukaemia drug Glivec (imatinib) in South Korea. Information released through the website of Ip-health, ...
FDA nod for Aurobindo's OTC cetirizine solution
05 February 2010
Aurobindo Pharma has received final US FDA approval for cetirizine hydrochloride solution 1mg/mL (OTC), a generic version of McNeil Consumer Healthcare Children's Zyrtec oral solution 1 mg/mL and ...
 
PEOPLE
Arthur Higgins joins board at Resverlogix Arthur Higgins , CEO of Bayer HealthCare and chairman of the Bayer HealthCare executive committee, ...
New appointments at Onyx Pharmaceuticals Onyx Pharmaceuticals (US) has appointed Dr Ted Love executive vice-president and head of R&D. Dr ...
Biota appoints new director Biota Holdings (Australia) has appointed Professor Jeffery Errington non-executive director. ...
>> More People News...

EXPERT VIEW
Biotech funding is available - for companies with a clear plan
08 February 2010
Ian Schofield
2009 may have been a lean year for biotech firms, but things seem to be looking up and some small ...

Market Insight - Microdosing reaching a tipping point?
05 February 2010

Advocates of microdosing, a technique that involves testing very small doses of products in humans, ...

 Market Insight - How the IMI is reinvigoratin...
 Market Insight- The cost of donated drugs...

Market Insight - Originator/generic competition: who's the 'bad guy'?
28 January 2010

Intellectual property rights are key elements of the fierce competition between originator and ...

Market Insight- The cost of donated drugs
25 January 2010

The Haiti earthquake has led to a flurry of drug donations. As new World Health Organization ...

MULTIMEDIA
Scrip in a minute - week ending February 5th 05 February 2010

Get the Flash Player to see this player.

Comment: Is Bulgaria's decision to close hospitals premature?
04 February 2010
Maria Bailey
Bulgaria's government is close to implementing major changes to its national healthcare services to ...

European Medicines Agency and logos: snakes, DNA and the pestle and mortar
22 December 2009
Elizabeth Sukkar
Logos are said to be an important part of an organisation's branding. Really good logos contribute ...

Interview: European Medicines Agency gets serious about its global strategy
29 January 2010
Elizabeth Sukkar
Developing relationships with medicine regulators in China and India is just one of the challenges ...

CPhI Worldwide 2009
13 October 2009
Scrip's official preview of CPhI Worldwide, ICSE, P-MEC and BioPh 2009

Scrip's Stock Tracker: December 2009
12 January 2010
Ashley Yeo
In the equity markets, the investor wariness that was apparent during November continued into ...

EVENTS
10 February 2010
London, UK
11 February 2010
London, UK
23 February 2010
London, UK
JOB OF THE WEEK Promote your vacancy here
DIRECTORY Scrip Directory 2009
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36
Home
Therapy Sector
Generics
Business
Policy & Regulation
Research & Development
International
Terms & Conditions
Privacy Policy
Sitemap
About Us
Advertise
Subscribe
Scrip
Clinica
RAJ
Scrip Clinical Research
Animal Pharm